These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7633691)

  • 1. Local nasal immunotherapy. Has the time come?
    Naclerio RM
    Am J Respir Crit Care Med; 1995 Aug; 152(2):425-6. PubMed ID: 7633691
    [No Abstract]   [Full Text] [Related]  

  • 2. Nasal immunotherapy to Parietaria: evidence of reduction of local allergic inflammation.
    Passalacqua G; Albano M; Ruffoni S; Pronzato C; Riccio AM; Di Berardino L; Scordamaglia A; Canonica GW
    Am J Respir Crit Care Med; 1995 Aug; 152(2):461-6. PubMed ID: 7633693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specific brief immunotherapy receives MMW Drug Prize 2004. Four pricks expel pollen allergy].
    Füessl HS
    MMW Fortschr Med; 2004 Sep; 146(37):13. PubMed ID: 15887695
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis.
    Dahl R; Kapp A; Colombo G; de Monchy JG; Rak S; Emminger W; Rivas MF; Ribel M; Durham SR
    J Allergy Clin Immunol; 2006 Aug; 118(2):434-40. PubMed ID: 16890769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoid sublingual immunotherapy.
    Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML
    Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous specific immunotherapy for seasonal allergic rhinitis: a review of treatment practices in the US and Europe.
    Cox L; Calderon MA
    Curr Med Res Opin; 2010 Dec; 26(12):2723-33. PubMed ID: 20979432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of nasal immunotherapy to Parietaria: clinical and local immunological effects.
    Passalacqua G; Albano M; Pronzato C; Riccio AM; Scordamaglia A; Falagiani P; Canonica GW
    Clin Exp Allergy; 1997 Aug; 27(8):904-8. PubMed ID: 9291287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local nasal immunotherapy: efficacy and tolerability of two different administration schedules in grass pollen rhinitis.
    Senna GE; Andri G; Dama AR; Falagiani P; Andri L
    Allergol Immunopathol (Madr); 2000; 28(4):238-42. PubMed ID: 11022271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of immunotherapy on the pathophysiology of ragweed pollen allergy.
    Ford SA; Baroody FM; Naclerio RM
    Rhinol Suppl; 1992; 14():52-6. PubMed ID: 1389403
    [No Abstract]   [Full Text] [Related]  

  • 11. SQ-standardised grass tablet sublingual immunotherapy: persistent clinical benefit and progressive immunological changes during three years treatment.
    Durham SR
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():121-7; discussion 127-31. PubMed ID: 20799452
    [No Abstract]   [Full Text] [Related]  

  • 12. Short-term efficacy of nasal immunotherapy.
    Palma-Carlos AG; Santos AS; Pregal A
    Allerg Immunol (Paris); 1998 Jan; 30(1):14-7. PubMed ID: 9503098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy.
    Nouri-Aria KT; Pilette C; Jacobson MR; Watanabe H; Durham SR
    J Allergy Clin Immunol; 2005 Jul; 116(1):73-9. PubMed ID: 15990777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy?
    Werfel T
    J Allergy Clin Immunol; 2009 Nov; 124(5):1003-4. PubMed ID: 19895988
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence-based practice: sublingual immunotherapy for allergic rhinitis.
    Wise SK; Schlosser RJ
    Otolaryngol Clin North Am; 2012 Oct; 45(5):1045-54. PubMed ID: 22980684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage.
    Durham SR; Riis B
    Allergy; 2007 Aug; 62(8):954-7. PubMed ID: 17620075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.
    Campbell DE
    Paediatr Respir Rev; 2009 Jun; 10(2):69-74; quiz 74. PubMed ID: 19410205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual immunotherapy affects transforming growth factor-beta and nasal eosinophils.
    Ciprandi G; Tosca MA
    Clin Exp Allergy; 2010 Sep; 40(9):1431-2; author reply 1432. PubMed ID: 20701617
    [No Abstract]   [Full Text] [Related]  

  • 20. Sublingual immunotherapy: where do we stand? Present and future.
    Passalacqua G; Pawankar R; Baena-Cagnani CE; Canonica GW
    Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):1-3. PubMed ID: 19106697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.